{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:56Z","timestamp":1790352536658,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ejphar.2017.03.019","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T01:18:33Z","timestamp":1489540713000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Inhibition of osteoporosis by the \u03b1v\u03b23 integrin antagonist of rhodostomin variants"],"prefix":"10.1016","volume":"804","author":[{"given":"Tzu-Hung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-Ju","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houng-Chi","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woie-Jer","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Mei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6937","key":"10.1016\/j.ejphar.2017.03.019_bib1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejphar.2017.03.019_bib2","first-page":"127","article-title":"Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro","volume":"1","author":"Chambers","year":"1986","journal-title":"Bone Miner."},{"issue":"Pt 1","key":"10.1016\/j.ejphar.2017.03.019_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1242\/jcs.103.1.267","article-title":"Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture","volume":"103","author":"Clover","year":"1992","journal-title":"J. Cell Sci."},{"issue":"4 Pt 1","key":"10.1016\/j.ejphar.2017.03.019_bib4","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1083\/jcb.109.4.1817","article-title":"The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor","volume":"109","author":"Davies","year":"1989","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.ejphar.2017.03.019_bib5","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1172\/JCI119404","article-title":"A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo","volume":"99","author":"Engleman","year":"1997","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.ejphar.2017.03.019_bib6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/endo.132.3.8440195","article-title":"Inhibition of osteoclastic bone resorption in vivo by echistatin, an \"arginyl-glycyl-aspartyl\" (RGD)-containing protein","volume":"132","author":"Fisher","year":"1993","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ejphar.2017.03.019_bib7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/prot.1061","article-title":"Expression in Pichia pastoris and characterization by circular dichroism and NMR of rhodostomin","volume":"43","author":"Guo","year":"2001","journal-title":"Proteins"},{"issue":"2","key":"10.1016\/j.ejphar.2017.03.019_bib8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0014-4827(91)90386-9","article-title":"Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts","volume":"195","author":"Horton","year":"1991","journal-title":"Exp. Cell Res."},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2017.03.019_bib9","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1007\/BF03194355","article-title":"Diagnosis of osteoporosis","volume":"7","author":"Kanis","year":"1997","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.ejphar.2017.03.019_bib10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.bone.2007.06.017","article-title":"PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats","volume":"41","author":"Lin","year":"2007","journal-title":"Bone"},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2017.03.019_bib11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejphar.2008.04.060","article-title":"Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate","volume":"589","author":"Lin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2017.03.019_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jcp.22008","article-title":"Upregulation of heme-oxygenase-1 inhibits the maturation and mineralization of osteoblasts","volume":"222","author":"Lin","year":"2010","journal-title":"J. Cell Physiol."},{"issue":"4","key":"10.1016\/j.ejphar.2017.03.019_bib13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1172\/JCI8905","article-title":"Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts","volume":"105","author":"McHugh","year":"2000","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.ejphar.2017.03.019_bib14","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1210\/jc.2004-2126","article-title":"Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women","volume":"90","author":"Murphy","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ejphar.2017.03.019_bib15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00774-007-0773-9","article-title":"Involvement of alpha(v)beta3 integrins in osteoclast function","volume":"25","author":"Nakamura","year":"2007","journal-title":"J. Bone Min. Metab."},{"issue":"12","key":"10.1016\/j.ejphar.2017.03.019_bib16","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1210\/endo.139.12.6375","article-title":"Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells","volume":"139","author":"Nakamura","year":"1998","journal-title":"Endocrinology"},{"issue":"5484","key":"10.1016\/j.ejphar.2017.03.019_bib17","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ejphar.2017.03.019_bib18","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1359\/JBMR.050724","article-title":"Critical role of beta3 integrin in experimental postmenopausal osteoporosis","volume":"20","author":"Zhao","year":"2005","journal-title":"J. Bone Miner. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917301899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917301899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T23:54:26Z","timestamp":1719100466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917301899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":18,"alternative-id":["S0014299917301899"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.03.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of osteoporosis by the \u03b1v\u03b23 integrin antagonist of rhodostomin variants","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}